Follow The Filings

CAMT Camtek

Camtek earnings company data as of 4:47 AM ET 10/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS 0.88 — —
Rev — — —

Insider trades

Open-market buys and sales by CAMT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CAMT insider trades
  • None no insider bought on the open market
  • $5.1M sold by 6 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Orit Geva-Dvash Vice President, HR
    Sale
    $89K 508 shares at $175.00 8.9% of stake
    Traded Aug 17 Filed Aug 18
  2. Karni Yarl Andorn Director
    Sale
    $928K 5,532 shares at $167.79 81% of stake
    Traded Aug 13–14 Filed Aug 17
  3. Ram Langer COO
    Sale
    $1.1M 6,387 shares at $172.32 27% of stake
    Traded Aug 13 Filed Aug 17
  4. Rafi Amit CEO
    Sale
    $1.1M 6,250 shares at $170.52 10% of stake
    Traded Aug 13 Filed Aug 17
  5. Orit Geva-Dvash Vice President, HR
    Sale
    $72K 415 shares at $174.06 6.8% of stake
    Traded Aug 12 Filed Aug 13
  6. Lior Aviram Director
    Sale
    $1.1M 6,694 shares at $168.43 35% of stake
    Traded Aug 11–12 Filed Aug 13
  7. Moshe Eisenberg CFO
    Sale
    $713K 4,404 shares at $161.90 21% of stake
    Traded Aug 11–12 Filed Aug 13

Also filed in the last 12 months, not counted as buying or selling: 4 stock grants and 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G —
6-K
6-K
SCHEDULE 13G —
6-K
6-K
SCHEDULE 13G/A —
SCHEDULE 13G/A —
6-K
6-K
6-K
6-K
SCHEDULE 13G/A —
SCHEDULE 13G/A —
6-K
6-K
20-F
6-K
SCHEDULE 13G —
SCHEDULE 13G/A —
6-K
6-K
SCHEDULE 13G —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.